Hospice enforcement has entered a structurally different phase. Oversight is no longer episodic or complaint‑driven; it is continuous, data‑driven, and predictive. Federal agencies increasingly identify risk through utilization analytics — length of stay, live discharges, diagnosis mix, and level‑of‑care patterns — before auditors ever review records. By the time a hospice receives an audit or payment action, the organization has often already been characterized as an outlier.
Recent enforcement illustrates this shift. In April 2026, federal authorities announced arrests in Operation Never Say Die, charging hospice operators with more than $50 million in alleged Medicare fraud. In the Topanga Hospice Care matter, investigators cited an 85% non‑death discharge rate — nearly five times the national average — as a key indicator that patients were not terminally ill. Data analytics surfaced the pattern; medical‑record review confirmed ineligibility. That same month, Centers for Medicare &